Study Of The PF-04958242 Blood Concentrations Of A Capsule Formulation Of PF-04958242 Compared To A Solution Formulation
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study will assess the relative bioavailability of a capsule formulation of PF-04958242,
relative to a oral solution formulation of PF-04958242 in healthy adult subjects.